MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
May 03, 2024 07:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, May 03, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 02, 2024 07:30 ET
|
Arbutus Biopharma Corporation
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001...
MYR Group Inc. Announces First-Quarter 2024 Results
May 01, 2024 16:13 ET
|
MYR Group, Inc.
THORNTON, Colo., May 01, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial...
FAT BRANDS INC. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
May 01, 2024 16:05 ET
|
FAT Brands Inc.
Conference call and webcast today at 5:00 p.m. ET LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today...
Credit Acceptance Announces First Quarter 2024 Results
April 30, 2024 16:01 ET
|
Credit Acceptance Corporation
Southfield, Michigan , April 30, 2024 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced...
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
April 26, 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
April 25, 2024 07:00 ET
|
Optinose, Inc.
YARDLEY, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Eagle Bancorp, Inc. Announces Results of Operations for First Quarter 2024
April 24, 2024 16:05 ET
|
Eagle Bancorp, Inc.
BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (the "Company") (NASDAQ: EGBN), the parent company of EagleBank (the "Bank"), today announced a net loss of $338 thousand for...
Retail Opportunity Investments Corp. Reports 2024 First Quarter Results
April 23, 2024 16:15 ET
|
Retail Opportunity Investments Corp.
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three months ended March 31, 2024. ...
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
April 22, 2024 06:45 ET
|
BioNTech SE
MAINZ, Germany, April 22, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024....